Price-shifting Strategies Could Affect Patients’ Out-of-pocket Costs

In a post on www.reuters.com, Reuters reporter Lisa Rapaport examines proposals on the table to reduce drug spending primarily through shifting coverage to standalone Part D plans. Her analysis points to the potential for increased spending by patients that could result from the shift. Read her post here…

Notice: Any links provided in this post above connect readers to the full content of the referenced article. The URL (internet address) for these links are valid on the posted date; medicarereport.org cannot guarantee the duration of the links' validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.